Medical Simulation Medical Graphic
Medical Animation | MOA | Medical Illustration | Holo 3D | General 3D | Video Game Development | Contact

Biotechnology Animations – Biotechnology Illustrations

Clinical Animations / Trial Animations

Clinical Studies Animated Method of Action Video

Medical Animation Studio produces clinical animations and clinical illustrations.  Custom 3d trail illustrations and clinical illustrations for e learning can also be produced.   Biotechnology animations and biotechnology illustrations created for biotech companies and biotechnology marketing companies.
Biotechnology animated method of action video. 
Dr Nano
Placebo delivery method affects patient response
1. Placebo delivery method affects patient response to "therapy"A systematic evidence review published in Annals of Internal Medicine finds that the way in which a placebo is delivered makes a...
Aromatase inhibitors 'significantly reduce breast cancer deaths'
A study finds a class of hormonal drugs - aromatase inhibitors - are more effective than tamoxifen for reducing mortality among women with ER-positive breast cancer.
Bavarian Nordic announces initiation of NCI-sponsored phase 2 study of PROSVAC in patients with localized prostate cancer
Bavarian Nordic A/S has announced that the first patient has been enrolled in a new phase 2 clinical study of PROSTVAC, the Company's active prostate cancer immunotherapy candidate.
Positive topline results announced from brincidofovir pivotal study in animal model for smallpox
Chimerix, Inc., a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced that its investigational antiviral brincidofovir showed a survival...
Study seeks newly diagnosed prostate cancer patients and caregivers to measure impact of evidence-based educational materials
A study funded by the Patient-Centered Outcomes Research Institute (PCORI) and conducted by researchers at Moffitt Cancer Center seeks participants to determine the effectiveness of educational...
Positive initial phase 2a study data with ANAVEX 2-73 showing early evidence of improving cognition in patients with Alzheimer's disease
Anavex Life Sciences Corp. has announced initial positive cognitive data for ANAVEX 2-73, the Company's lead investigational oral treatment for Alzheimer's targeting sigma-1 and muscarinic...
New data presented from phase 1b study of investigational Alzheimer's disease treatment Aducanumab (BIIB037)
Today Biogen has announced new results from a prespecified interim analysis of PRIME, the Phase 1b placebo-controlled study of aducanumab (BIIB037) in patients with prodromal or mild Alzheimer's...
Alzheimer's Association International Conference 2015: the highlights
As the 2015 Alzheimer's Association International Conference draws to a close, we look at some of the studies leading us closer to prevention and treatment strategies for dementia.
Investors join patients' and doctors' call for clinical trial transparency
Investors representing more than €3.5 trillion of assets under management now support the AllTrials1 campaign and are asking the pharmaceutical companies they invest in to set out plans to...
Alzheimer's patients may benefit from early treatment with novel drug
The first ever Alzheimer’s disease clinical trial to use delayed-start methodology has found that patients with a mild form of the disease benefit from beginning treatment early.
InnaVirVax presents highly encouraging results of its first clinical study on VAC-3S immunotherapy for HIV
InnaVirVax, a biopharmaceutical company specialized in research and development of therapeutic and diagnostic solutions for major infectious and chronic diseases, has announced the overall results...
Leading scientists call for new approach to research reporting
A prominent neuroscientist has co-authored a paper urging scientists to adopt a new style of reporting that enables them to publish research faster and more succinctly.
New drug could improve potassium levels of diabetic kidney disease patients
A new drug for the treatment of hyperkalemia has shown promise in a phase 2 clinical trial involving patients with diabetes receiving RAAS inhibitors.
Phase 2 study of the Ebola prime-boost vaccine regimen combining MVA-BN Filo and Advac technology initiated
Bavarian Nordic A/S has announced that the Oxford Vaccines Group has initiated a Phase 2 clinical study of the Ebola prime-boost vaccine regimen that combines Bavarian Nordic's MVA-BN® Filo...
Antidepressant trials exclude most 'real world' patients with depression
More than 80 percent of people with depression in the general population aren't eligible for clinical trials of antidepressant drugs, according to a study in the Journal of Psychiatric Practice.
WindowsFlashQuicktime
Request Demo Reel DVD
Related Medical Animation Links

Copyright © 2015
Content Management / Website Design by Tresware